Oncolytics Biotech, Inc. (ONCY)
0.8899
-0.01
(-1.48%)
USD |
NASDAQ |
May 13, 11:36
Oncolytics Biotech Free Cash Flow : -19.96M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 10.23B |
| Karyopharm Therapeutics, Inc. | -75.37M |
| Replimune Group, Inc. | -283.27M |
| Sensei Biotherapeutics, Inc. | -22.40M |
| Tango Therapeutics, Inc. | -139.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.263M |
| Cash from Investing (Quarterly) | -0.0009M |
| Cash from Financing (Quarterly) | 2.609M |
| Free Cash Flow Per Share (Quarterly) | -0.058 |
| Free Cash Flow to Equity (Quarterly) | -6.211M |
| Free Cash Flow to Firm (Quarterly) | -6.264M |
| Free Cash Flow Yield | -23.30% |